KOLINPHARMA® obtains a patent in the United States of America for Dolatrox® - 10/03/2020

25 May 2020

Dolatrox® is a composition for the treatment of arthropathies and osteoarthritis, as stated in the patent certificate. This composition was thus recognized as innovative and unique. Dolatrox is the 4th patent that Kolinpharma obtains in the USA.

"Obtaining the fourth patent, in a country like the United States, a worldwide reference in scientific research, is a huge source of pride for us" - comments the president, Rita Paola Petrelli.

KOLINPHARMA® obtains a patent in the United States of America for Dolatrox® - 10/03/2020

Read More